BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,138 filers reported holding BAXTER INTL INC in Q4 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $7,266,000 | +10.5% | 83,069 | +3.4% | 0.14% | +6.2% |
| Q2 2019 | $6,578,000 | -1.8% | 80,323 | -11.5% | 0.13% | -13.9% |
| Q2 2018 | $6,698,000 | +5.5% | 90,711 | -7.0% | 0.15% | +3.4% |
| Q1 2018 | $6,346,000 | -20.0% | 97,578 | -20.5% | 0.15% | -21.5% |
| Q4 2017 | $7,930,000 | +105.8% | 122,680 | +99.8% | 0.19% | +77.1% |
| Q3 2017 | $3,854,000 | -24.0% | 61,415 | -26.7% | 0.10% | -27.1% |
| Q2 2017 | $5,074,000 | +1.4% | 83,813 | -13.1% | 0.14% | -0.7% |
| Q1 2017 | $5,002,000 | +58.2% | 96,449 | +35.3% | 0.14% | +45.0% |
| Q4 2016 | $3,161,000 | -39.1% | 71,280 | -34.6% | 0.10% | -42.5% |
| Q3 2016 | $5,192,000 | +23.7% | 109,066 | +17.5% | 0.17% | +18.4% |
| Q2 2016 | $4,197,000 | -4.5% | 92,814 | -13.2% | 0.15% | -6.4% |
| Q1 2016 | $4,393,000 | – | 106,940 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tavio Capital LLC | 68,405 | $5,890,000 | 7.81% |
| Iron Triangle Partners LP | 330,000 | $28,413,000 | 7.16% |
| Veritas Asset Management LLP | 8,942,428 | $769,943,000 | 5.64% |
| TSFG, LLC | 93,405 | $8,042,000 | 5.31% |
| GENERATION INVESTMENT MANAGEMENT LLP | 10,606,094 | $913,185,000 | 5.27% |
| Third Point | 4,000,000 | $344,400,000 | 4.72% |
| Avidity Partners Management LP | 800,900 | $68,957,000 | 4.42% |
| Palmer Knight Co | 62,275 | $5,362,000 | 4.17% |
| Eos Focused Equity Management, L.P. | 36,786 | $3,167,000 | 3.70% |
| Dundas Partners LLP | 196,133 | $16,887,000 | 3.69% |